首页 › 胶质母细胞瘤 › 明尼苏达州 › Rochester
Rochester MN 胶质母细胞瘤临床试验
13项针对 胶质母细胞瘤的研究正在 Rochester及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
招募中2 期
- Mayo Clinic in Rochester, Rochester
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
招募中1/2 期
- Mayo Clinic in Rochester, Rochester
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
招募中3 期
- Mayo Clinic - Rochester, Rochester
Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
招募中早期 I 期
- Mayo Clinic in Rochester, Rochester
Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions
招募中
- Mayo Clinic in Rochester, Rochester
Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
招募中
- Mayo Clinic in Rochester, Rochester
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
招募中
- Mayo Clinic in Rochester, Rochester
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
招募中2 期
- Mayo Clinic, Rochester
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
招募中1/2 期
- Mayo Clinic in Rochester, Rochester
ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
招募中1 期
- Mayo Clinic in Rochester, Rochester
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
招募中1/2 期
- Mayo Clinic Hospital, Rochester
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
招募中1/2 期
- Mayo Clinic Cancer Center, Rochester
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
招募中2 期
- Mayo Clinic, Rochester
其他城市的 胶质母细胞瘤试验
- New York City, NY30 项研究
- Boston, MA28 项研究
- Houston, TX26 项研究
- Los Angeles, CA24 项研究
- Durham, NC20 项研究
- San Francisco, CA17 项研究
- Chicago, IL15 项研究
- Washington, DC15 项研究
- Columbus, OH14 项研究
- Miami, FL14 项研究
- Jacksonville, FL13 项研究
- Aurora, CO12 项研究
Rochester的其他研究
- 乳腺癌42 项研究
- 非小细胞肺癌37 项研究
- 转移性癌症31 项研究
- 癌症（所有类型）30 项研究
- 卵巢癌29 项研究
- 结直肠癌29 项研究
- 多发性骨髓瘤24 项研究
- 心力衰竭22 项研究
- 前列腺癌22 项研究
- 胰腺癌22 项研究
- 子宫内膜癌20 项研究
- 肺癌20 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。